Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer.
Explore this paper's citation graph
Summary
Observations show that the surgical procedure itself can cause the presence of CTCs in the peripheral blood, and this demonstrates the heterogeneity of the CTC population among patients.
- Type
- article
- Published
- 2013-05-01
- Cited by
- 37
- References
- 0
- OpenAlex
- https://openalex.org/W1790485911
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31177602
Keywords
Medicine, Carcinoembryonic antigen, Circulating tumor cell, Colorectal cancer, Chemotherapy
References
No references recorded for this paper.
Cited by
- Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.
- The Internet of Things for Health Care: A Comprehensive Survey
- Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation
- The Clinical Potential of Circulating Tumor Cells and Circulating Tumor-Associated Cellular Elements in Colorectal Cancer
- Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
- Circulating Tumor Cells: A Window to Understand Cancer Metastasis, Monitor and Fight Against Cancers
- Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis
- Cloud enabled data analytics and visualization framework for health-shocks prediction
- Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
- Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
- Long-term consequences of the acute neural-inflammatory stress response in the cancer surgical patient: New findings and perspectives
- Role of pulmonary macrophages in initiation of lung metastasis in anaplastic thyroid cancer
- Making the Case for the Subspecialty of Onco-Anesthesia
- Impact of Intra‐ and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy
- Effect of propofol on androgen receptor activity in prostate cancer cells
- Peri‐operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score‐weighted European multicentre study
- Timing of blood transfusion and oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma
- Potential impact of invasive surgical procedures on primary tumor growth and metastasis
- What Is the Future of Circulating Tumor Cells in Colorectal Cancer?
- Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma
Related papers
- Clinical Treatment of Colorectal Cancer Complicated by Bowel Obstruction: Experience with 42 Cases
- The advantage of circulating tumor cells over serum carcinoembryonic antigen for predicting treatment responses in rectal cancer.
- Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer.
- Predictive value of tissue inhibitor of metalloproteinases-1 and carcinoembryonic antigen plasma levels in response to chemotherapy in patients with metastatic colorectal cancer
- Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.
- Enumerating Circulating Tumor Cells with a Self-Assembled Cell Array (SACA) Chip: A Feasibility Study in Patients with Colorectal Cancer
- Carcinoembryonic Antigen-related Tumor Kinetics After Eight Weeks of Chemotherapy is Independently Associated With Overall Survival in Patients With Metastatic Colorectal Cancer.
- Carcinoembryonic antigen in monitoring of response to cetuximab plus FOLFIRI or FOLFOX-4 in patients with metastatic colorectal cancer.
- Carcinoembryonic Antigen in Monitoring of Response to Cetuximab plus FOLFIRI or FOLFOX-4 in Patients with Metastatic Colorectal Cancer
- Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®